Immunogenicity, Reactogenicity of Shingrix in SLE

Clinical trial NCT06001606 · UNKNOWN

Trial details

NCT number: NCT06001606
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Zoster Systemic Lupus Erythematosus Vaccine Reaction

Start date: 2023-05-08
Primary completion: 2025-04-24
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.